MARVELD1 抗体 (AA 31-130)
-
- 抗原 See all MARVELD1 抗体
- MARVELD1 (MARVEL Domain Containing 1 (MARVELD1))
-
抗原表位
- AA 31-130
-
适用
- 小鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This MARVELD1 antibody is un-conjugated
- 应用范围
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 交叉反应
- 小鼠
- 预测反应
- Human,Rabbit
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human MARVELD1
- 亚型
- IgG
- Top Product
- Discover our top product MARVELD1 Primary Antibody
-
-
- 应用备注
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 有效期
- 12 months
-
- 抗原
- MARVELD1 (MARVEL Domain Containing 1 (MARVELD1))
- 别名
- MARVELD1 (MARVELD1 产品)
- 别名
- Mrvldc1 antibody, AI504298 antibody, GB14 antibody, MARVD1 antibody, MRVLDC1 antibody, RP11-548K23.8 antibody, bA548K23.8 antibody, MARVEL domain containing 1 antibody, MARVEL (membrane-associating) domain containing 1 antibody, Marveld1 antibody, MARVELD1 antibody
- 背景
-
Synonyms: GB14, MARVD1, MARVEL membrane-associating domain containing 1, MARVEL domain containing protein 1, MRVLDC1, Putative MARVEL domain containing protein 1, MALD1_HUMAN.
Background: MARVELD1, (MARVEL domain-containing 1), is one of the MARVEL (MAL and related proteins for vesicle trafficking and membrane link) domain-containing proteins. It is a nuclear-localized protein that is widely expressed in normal human tissues. While it has been reported to be overexpressed in colon cancer, MARVELD1 protein levels are generally lower in several primary tumors including ovary, breast, kidney, bladder and liver. This lower level of MARVELD1 expression in tumors is thought to be due to a higher methylation status of the MARVELD1 promoter as treatment of MDA-MB-361 with 5-aza-2'-deoxycytidine restores MARVELD1 expression, suggesting that loss of MARVELD1 expression may contribute to tumorgenicity.
- 基因ID
- 83742
-